As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: October 27, 2014
by Julie Flaherty for Medical XPress:
Researchers have known for a while that getting enough lutein in your diet seems to be a good thing for eye health; people who consume more of this deep yellow pigment found in dark green leafy vegetables and brightly colored fruits are less likely to develop age-related macular degeneration, for example. But lutein may have a special role in brain health as well.
In an article she wrote for the journal Nutrition Reviews, Elizabeth Johnson, a scientist in the Antioxidants Research Laboratory at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts, makes a case for studying lutein’s cognitive benefits. She points out that the brain absorbs more lutein than it does other carotenoids (including beta carotene and lycopene).
One study found that having a lutein-rich brain was associated with better marks on a wide range of cognitive measures, including executive function, language, learning and memory.
The need for lutein may start early. Johnston writes that because children have twice the percentage of lutein in their brains as adults, there is a good chance that lutein is important for neural development during the first years of life.
Unfortunately, most Americans don’t get enough lutein. While there is no recommended dietary allowance for lutein, it takes 6 mg per day to lower the risk of age-related macular degeneration. The average adult gets less than 2 mg per day. Kale, collards and spinach are the lutein powerhouses, but you can also find it in broccoli, eggs and avocados, among other places.
Thirty-six million people worldwide suffer from Alzheimer’s disease and dementia. In Canada, 25,000 new cases are diagnosed each year. Those sobering numbers have researchers around the globe racing to come up with new ways to...
he Food and Drug Administration issued new guides on drug development for neurological disorders. This sets the stage for possible treatments for Alzheimer’s. The disease-oriented development guide documents will provide details on how researchers...
For young adults with autosomal dominant Alzheimer’s disease (AD), molecular markers can identify changes associated with the disease before clinical onset, according to a study published online Feb. 12 in JAMA Neurology. Yakeel T. Quiroz, Ph.D., from Massachusetts...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.